Metis Global Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Sell |
7,420
-389
| -5% | -$85.1K | 0.04% | 355 |
|
|
2025
Q1 | $1.75M | Buy |
7,809
+1,379
| +21% | +$309K | 0.05% | 337 |
|
|
2024
Q4 | $2.11M | Buy |
6,430
+211
| +3% | +$69.1K | 0.06% | 267 |
|
|
2024
Q3 | $1.87M | Buy |
6,219
+500
| +9% | +$150K | 0.06% | 301 |
|
|
2024
Q2 | $1.88M | Buy |
5,719
+219
| +4% | +$72.1K | 0.06% | 261 |
|
|
2024
Q1 | $2.18M | Buy |
5,500
+66
| +1% | +$26.1K | 0.08% | 224 |
|
|
2023
Q4 | $1.91M | Buy |
5,434
+138
| +3% | +$48.6K | 0.08% | 250 |
|
|
2023
Q3 | $1.99M | Buy |
5,296
+425
| +9% | +$159K | 0.1% | 217 |
|
|
2023
Q2 | $1.86M | Buy |
4,871
+571
| +13% | +$218K | 0.1% | 211 |
|
|
2023
Q1 | $1.49M | Sell |
4,300
-72
| -2% | -$24.9K | 0.1% | 226 |
|
|
2022
Q4 | $1.03M | Buy |
4,372
+2,144
| +96% | +$505K | 0.09% | 249 |
|
|
2022
Q3 | $549K | Buy |
2,228
+529
| +31% | +$130K | 0.09% | 269 |
|
|
2022
Q2 | $513K | Buy |
1,699
+526
| +45% | +$159K | 0.08% | 284 |
|
|
2022
Q1 | $482K | Buy |
1,173
+527
| +82% | +$217K | 0.06% | 308 |
|
|
2021
Q4 | $303K | Buy |
+646
| New | +$303K | 0.08% | 272 |
|